Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | L | Common Stock | Options Exercise | $0 | +6.69K | +95.68% | $0.00 | 13.7K | Feb 10, 2022 | Direct | F1 |
transaction | L | Common Stock | Tax liability | -$228K | -3.7K | -27.05% | $61.58 | 9.98K | Feb 10, 2022 | Direct | F2 |
transaction | L | Common Stock | Options Exercise | $524K | +11.3K | +112.69% | $46.58 | 21.2K | Feb 10, 2022 | Direct | |
transaction | L | Common Stock | Options Exercise | $488K | +11.3K | +52.98% | $43.37 | 32.5K | Feb 10, 2022 | Direct | |
transaction | L | Common Stock | Options Exercise | $493K | +11.3K | +34.63% | $43.83 | 43.7K | Feb 10, 2022 | Direct | |
transaction | L | Common Stock | Options Exercise | $472K | +11.3K | +25.72% | $41.98 | 55K | Feb 10, 2022 | Direct | |
transaction | L | Common Stock | Options Exercise | $228K | +5.63K | +10.23% | $40.46 | 60.6K | Feb 10, 2022 | Direct | |
transaction | L | Common Stock | Options Exercise | $228K | +5.63K | +9.28% | $40.61 | 66.2K | Feb 10, 2022 | Direct | |
transaction | L | Common Stock | Disposed to Issuer | -$2.43M | -39.4K | -59.43% | $61.82 | 26.9K | Feb 10, 2022 | Direct | |
transaction | L | Common Stock | Sale | -$1.05M | -16.9K | -62.85% | $61.96 | 9.98K | Feb 10, 2022 | Direct | F3 |
transaction | L | Common Stock | Options Exercise | $0 | +7.41K | +74.27% | $0.00 | 17.4K | Feb 11, 2022 | Direct | F4 |
transaction | L | Common Stock | Tax liability | -$255K | -4.1K | -23.57% | $62.10 | 13.3K | Feb 11, 2022 | Direct | F5 |
transaction | L | Common Stock | Sale | -$80.8K | -1.3K | -9.8% | $62.03 | 12K | Feb 14, 2022 | Direct | F6 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | L | Restricted Stock Units | Options Exercise | $0 | -6.69K | -50% | $0.00 | 6.69K | Feb 10, 2022 | Common Stock | 6.69K | Direct | F1, F7 | |
transaction | L | Stock Appreciation Right | Options Exercise | $0 | -11.3K | -100% | $0.00* | 0 | Feb 10, 2022 | Common Stock | 11.3K | $46.58 | Direct | F8, F9 |
transaction | L | Stock Appreciation Right | Options Exercise | $0 | -11.3K | -100% | $0.00* | 0 | Feb 10, 2022 | Common Stock | 11.3K | $43.37 | Direct | F8, F9 |
transaction | L | Stock Appreciation Right | Options Exercise | $0 | -11.3K | -100% | $0.00* | 0 | Feb 10, 2022 | Common Stock | 11.3K | $43.83 | Direct | F8, F9 |
transaction | L | Stock Appreciation Right | Options Exercise | $0 | -11.3K | -100% | $0.00* | 0 | Feb 10, 2022 | Common Stock | 11.3K | $41.98 | Direct | F8, F9 |
transaction | L | Stock Appreciation Right | Options Exercise | $0 | -5.63K | -100% | $0.00* | 0 | Feb 10, 2022 | Common Stock | 5.63K | $40.46 | Direct | F9, F10 |
transaction | L | Stock Appreciation Right | Options Exercise | $0 | -5.63K | -100% | $0.00* | 0 | Feb 10, 2022 | Common Stock | 5.63K | $40.61 | Direct | F9, F10 |
transaction | L | Restricted Stock Units | Options Exercise | $0 | -7.41K | -100% | $0.00* | 0 | Feb 11, 2022 | Common Stock | 7.41K | Direct | F4, F7 |
Id | Content |
---|---|
F1 | Represents the conversion upon vesting of restricted stock units ("RSUs") into common stock. On February 10, 2020, the Reporting Person was awarded 13,382 RSUs, subject to the Issuer achieving a pre-determined level of performance based income ("PBI Metric") for 2020. The Issuer's Compensation Committee determined that the Issuer achieved the PBI Metric on February 8, 2021 and the 2020 RSUs were then reported on a Form 4 filed with the Securities and Exchange Commission (the "SEC"). 50% of these RSUs vested on February 10, 2022. The remaining 2020 RSUs will vest on February 10, 2023. Shares of the Issuer's common stock will be delivered to the Reporting Person within 30 days after vesting, subject to any election to defer delivery of shares by the Reportig Person. |
F2 | The Reporting Person is reporting the withholding, by the Issuer, of 3,701 shares of common stock that vested in respect of the 2020 RSUs on February 10, 2022 but were not issued in order to satisfy the Reporting Person's tax withholding obligations in connection therewith. |
F3 | Represents the weighted average share price of multiple transactions with a range of prices between $61.51 and $62.20. The Reporting Person upon request by the SEC Staff, the Issuer or security holder of the Issuer, undertakes to provide further information regarding the number of securities at each separate price sold. |
F4 | Represents the conversion upon vesting of RSUs into common stock. On February 11, 2019, the Reporting Person was awarded 14,827 RSUs, subject to the Issuer achieving a PBI Metric for 2019. The Issuer's Compensation Committee determined that the Issuer achieved the PBI Metric on February 10, 2020 and the 2019 RSUs were then reported on a Form 4 filed with the SEC. 50% of these RSUs previously vested on February 11, 2021. The remaining 2019 RSUs vested on February 11, 2022. |
F5 | The Reporting Person is reporting the withholding, by the Issuer, of 4,100 shares of common stock that vested in respect of the 2019 RSUs on February 11, 2022 but were not issued in order to satisfy the Reporting Person's tax withholding obligations in connection therewith. |
F6 | Represents the weighted average share price of multiple transactions with a range of prices between $62.00 and $62.05. The Reporting Person upon request by the SEC Staff, the Issuer or security holder of the Issuer, undertakes to provide further information regarding the number of securities at each separate price sold. |
F7 | Each RSU represents a contingent right to receive one share of the Issuer's common stock. |
F8 | The Stock Appreciation Rights became exercisable in quarterly installments begininng on January 14, 2015. |
F9 | The Reporting Person received the Derivative Security pursuant to a stock appreciation right grant at no cost. |
F10 | The Stock Appreciation Rights became exercisable in quarterly installments beginning on January 9, 2016. |